FDX1 is a Potential Prognostic Biomarker Related to Cuproptosis and Immune Infiltration for Patients with Kidney Renal Clear Cell Carcinoma

Author:

Zhang Jiejia1

Affiliation:

1. Kansas State University

Abstract

Abstract Objective The aim of this study was to detect the correlation between the FDX1 (Cuproptosis-related gene) expression levels and overall survival, clinical characteristics, and immune infiltration for patients with KIRC. Results The FDX1 expression levels were lower in KIRC tumor tissues. The high expression of FDX1 was a positive prognosis factor since it had a significantly positive correlation with the overall survival of patients with KIRC. Also, the FDX1 expression levels had a negative association with the immune infiltrate levels and enriched effects on inflammation and immune signaling pathways. Conclusion FDX1 was a potential Cuproptosis-related prognostic biomarker for KIRC immunotherapy.

Publisher

Research Square Platform LLC

Reference42 articles.

1. Gropper SS, Smith JL, Carr TP. Essential Trace and Ultratrace Minerals. In Advanced Nutrition and Human Metabolism. 8th edition. Boston: Cenage Learning; 2021:557–565.

2. Copper metabolism as a unique vulnerability in cancer;Shanbhag VC;Biochimica et Biophysica Acta-Molecular Cell Research.,2021

3. Qu X, He Z, Qiao H, Zhai Z, Mao Z, Yu Z, et al. Serum copper levels are associated with bone mineral density and total fracture. J Orthop Translat 2018, 14:34–44.

4. Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion;Voli F;Cancer Res,2020

5. Copper induces cell death by targeting lipoylated TCA cycle proteins;Tsvetkov P;Science,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3